A combination phase I study of split doses of cisplatin plus etoposide with early concurrent accelerated hyperfractionated thoracic radiotherapy for elderly limited disease small cell lung cancer
Not Applicable
Recruiting
- Conditions
- limited disease small cell lung cancer
- Registration Number
- JPRN-UMIN000009407
- Lead Sponsor
- Department of Medical Oncology, Kinki University faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
1)Severe infection and complication (hemorrhage and heart disease etc.) 2)Intestinal pneumonia or lung fibrosis 3)History of severe drug allergic reaction 4)Pregnant women or women willing child bearing 5)Men willing to have children 6)Uncontrolled diabetes 7)Uncontrolled pleural, cardiac, or abdominal effusion 8)Fever over 38 degrees Celsius 9)History of thoratic radiation 10)Inadequate condition diagnosed by primary physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method